Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Sees Large Decline in Short Interest

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 541,500 shares, a drop of 47.9% from the February 28th total of 1,039,200 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is currently 5,415.0 days. Approximately 0.3% of the company’s stock are sold short.

Recordati Industria Chimica e Farmaceutica Price Performance

Recordati Industria Chimica e Farmaceutica stock remained flat at $55.54 during midday trading on Friday. The stock has a market cap of $11.46 billion, a P/E ratio of 27.77 and a beta of 0.30. The business has a 50 day simple moving average of $55.54 and a 200-day simple moving average of $53.72. Recordati Industria Chimica e Farmaceutica has a 12 month low of $52.25 and a 12 month high of $52.25.

Recordati Industria Chimica e Farmaceutica Company Profile

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.